Background It remains unclear whether total or subtotal parathyroidectomy for secondary
hyperparathyroidism yields the best outcomes. We investigated mortality, cardiovascular …

The Kidney Foundation of the USA proposed clinical practice guidelines for bone
metabolism and disease in chronic kidney disease including parathyroidectomy (PTx). We …

Background Main surgical treatments for secondary hyperparathyroidism (SHPT) include
subtotal parathyroidectomy (sPTX), total parathyroidectomy with autotransplantation (tPTX+ …

Background Secondary hyperparathyroidism (sHPT) is common in patients with chronic
renal failure. Despite the initiation of new therapeutic agents, several patients will require …

Background A significant proportion of patients with chronic kidney disease and secondary
hyperparathyroidism (HPT) remain hyperparathyroid after kidney transplantation, a state …

Parathyroidectomy (PTx) and medical treatments are both recommended for reducing serum
intact parathyroid hormone (iPTH) and curing secondary hyperparathyroidism (sHPT) in …

Chronic kidney disease mineral and bone disorder may persist after successful kidney
transplantation. Persistent hyperparathyroidism has been identified in up to 80% of patients …

Rising levels of parathyroid hormone (PTH) are common in patients with chronic kidney
disease (CKD) not on dialysis and are associated with an elevated risk of morbidity …

Background Parathyroid surgery (PTX) in patients with tertiary hyperparathyroidism (tHPT)
may endanger the long-term survival of transplanted renal grafts. The mechanism by which …

Secondary hyperparathyroidism (SHPT) remains a serious complication in patients with
chronic kidney disease, and some patients require parathyroidectomy. The Parathyroid …